DE69729839D1 - Attenuierter lebender Neospora Impfstoff - Google Patents

Attenuierter lebender Neospora Impfstoff

Info

Publication number
DE69729839D1
DE69729839D1 DE69729839T DE69729839T DE69729839D1 DE 69729839 D1 DE69729839 D1 DE 69729839D1 DE 69729839 T DE69729839 T DE 69729839T DE 69729839 T DE69729839 T DE 69729839T DE 69729839 D1 DE69729839 D1 DE 69729839D1
Authority
DE
Germany
Prior art keywords
attenuated live
live neospora
neospora vaccine
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69729839T
Other languages
English (en)
Other versions
DE69729839T2 (de
Inventor
David Brake
Byron Blagburn
David Lindsay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auburn University
Pfizer Inc
Original Assignee
Auburn University
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69729839(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Auburn University, Pfizer Inc filed Critical Auburn University
Publication of DE69729839D1 publication Critical patent/DE69729839D1/de
Application granted granted Critical
Publication of DE69729839T2 publication Critical patent/DE69729839T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69729839T 1996-11-12 1997-10-14 Attenuierter lebender Neospora Impfstoff Expired - Fee Related DE69729839T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12
US31248P 1996-11-12

Publications (2)

Publication Number Publication Date
DE69729839D1 true DE69729839D1 (de) 2004-08-19
DE69729839T2 DE69729839T2 (de) 2005-07-21

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729839T Expired - Fee Related DE69729839T2 (de) 1996-11-12 1997-10-14 Attenuierter lebender Neospora Impfstoff

Country Status (16)

Country Link
US (3) US6656479B2 (de)
EP (1) EP0841392B1 (de)
JP (2) JP3690709B2 (de)
CN (2) CN1226406C (de)
AR (2) AR010583A1 (de)
AT (1) ATE271122T1 (de)
AU (1) AU733076B2 (de)
BR (1) BR9705473A (de)
CA (1) CA2220588C (de)
DE (1) DE69729839T2 (de)
DK (1) DK0841392T3 (de)
ES (1) ES2224210T3 (de)
NZ (1) NZ329095A (de)
PT (1) PT841392E (de)
TW (1) TW557214B (de)
ZA (1) ZA9710130B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271122T1 (de) * 1996-11-12 2004-07-15 Pfizer Attenuierter lebender neospora impfstoff
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
KR20010024245A (ko) * 1997-10-20 2001-03-26 조지 제이. 리코스 네오스포라 백신
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
IL160966A0 (en) * 2001-10-31 2004-08-31 Pfizer Prod Inc Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
PT1646715E (pt) 2003-07-22 2010-08-09 Vivalis Produção de poxvírus com linhagem das células aviarias aderentes ou não aderentes
US7718165B2 (en) * 2003-12-19 2010-05-18 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
RU2473688C2 (ru) * 2006-08-09 2013-01-27 Вивалис Способ получения трансгенных птиц с использованием эмбриональных стволовых клеток
EP1985305A1 (de) 2007-04-24 2008-10-29 Vivalis Aus Entenembryonen gewonnene Stammzellkulturen zur Herstellung von Impfstoffen gegen Viren
EP1995309A1 (de) * 2007-05-21 2008-11-26 Vivalis Rekombinante Proteinproduktion in EBx -Vogelzellen
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
EP3368070B9 (de) 2015-10-28 2023-10-18 Universidad Complutense De Madrid Neospora-impstoffzusammensetzung
MX2019003947A (es) 2016-10-05 2019-06-10 Zoetis Services Llc Metodos de liofilizacion que proporcionan protozoos deshidratados de forma estable para uso como potentes vacunas vivas.
KR20210016446A (ko) 2018-05-30 2021-02-15 인스티튜트 포 리서치 인 바이오메드슨 내인성 활성화-유도 시티딘 탈아미노효소를 이용한 b 림프구의 조작
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
ATE271122T1 (de) * 1996-11-12 2004-07-15 Pfizer Attenuierter lebender neospora impfstoff
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
AR053286A2 (es) 2007-04-25
JPH10167983A (ja) 1998-06-23
EP0841392A3 (de) 1999-03-24
PT841392E (pt) 2004-11-30
TW557214B (en) 2003-10-11
JP2005230018A (ja) 2005-09-02
ZA9710130B (en) 1999-06-10
US6656479B2 (en) 2003-12-02
DK0841392T3 (da) 2004-11-22
AU4520397A (en) 1998-05-14
CN1226406C (zh) 2005-11-09
US20060073157A1 (en) 2006-04-06
AU733076B2 (en) 2001-05-03
DE69729839T2 (de) 2005-07-21
US20040062772A1 (en) 2004-04-01
CA2220588A1 (en) 1998-05-12
MX9708701A (es) 1998-09-30
BR9705473A (pt) 1999-04-06
JP3935180B2 (ja) 2007-06-20
NZ329095A (en) 1998-03-25
US6994861B2 (en) 2006-02-07
US20020044952A1 (en) 2002-04-18
EP0841392A2 (de) 1998-05-13
CN1190127A (zh) 1998-08-12
CA2220588C (en) 2008-07-22
AR010583A1 (es) 2000-06-28
EP0841392B1 (de) 2004-07-14
JP3690709B2 (ja) 2005-08-31
ES2224210T3 (es) 2005-03-01
ATE271122T1 (de) 2004-07-15
CN1572322A (zh) 2005-02-02

Similar Documents

Publication Publication Date Title
DE69729839D1 (de) Attenuierter lebender Neospora Impfstoff
NO991524D0 (no) Vaksiner
FI20095582A (fi) Röntgenkuvauslaitteisto
ID21031A (id) Kornea buatan
GB9711964D0 (en) Live attenuated vaccines
FI974420A (fi) Röntgenkuvauslaitteisto
ID17860A (id) Komposisi vaksin
DE59707666D1 (de) Gezogenes Gerät
DE69726222D1 (de) Photovervielfacher
DE69733812D1 (de) Heizkessel
DK0956042T3 (da) Mykosevaccine
DE59712036D1 (de) Computertomograph
ATE277631T1 (de) Neospora impstoff
NO971648L (no) Rör
NO303371B1 (no) Oppdrettsmerd
DE59609687D1 (de) Faltrollostange
KR960008272U (ko) 아파트 입상관 슬리브
KR960011347U (ko) 아파트식 분묘
KR960036206U (ko) 구두주걱
KR980000229U (ko) 주머니가 형성된 각반
KR970054891U (ko) 트랩
KR970048741U (ko) 쥐 포획기
KR970008136U (ko) 관
KR970056527U (ko) 숨쉬는 팬티스타킹
KR980004868U (ko) 회초리

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee